OTS

Education Resources, Inc. Releases New Online Course - "Baby Beats and Breaths: Therapeutic Interventions for the Premature Infant with Cardiopulmonary Compromise" with International Expert Holly Schifsky

Retrieved on: 
Wednesday, June 8, 2022
Person-centered therapy, OTR/L, Open educational resources, OTS, PTS, Multimedia, Therapy, ERI, Patient, Review, CNT, Education, Medicine, Online shopping

BOSTON, June 8, 2022 /PRNewswire/ -- Education Resources, Inc., a leading continuing education provider for physical therapists, occupational therapists, and speech-language pathologists, is pleased to announce the online launch of "Baby Beats and Breaths: Therapeutic Interventions for the Premature Infant with Cardiopulmonary Compromise", taught by internationally renowned instructor, Holly Schifsky, OTR/L, CNT, NTMTC, CBIS.

Key Points: 
  • Participants can register for "Baby Beats and Breaths: Therapeutic Interventions for the Premature Infant with Cardiopulmonary Compromise" on ERI's website and review ERI's complete list of online and live webinar offerings.
  • This online course was previously recorded from a live webinar in January 2022.
  • Participants can now access this exclusive online learning opportunity from the convenience or their home for $319/person.
  • The online format includes access to the entire course and all downloadable handout materials for one year, earning 14.5 contact hours (1.45 CEUs) upon completion.

Wiener's Dangerous 4 a.m. "Zombie" Bar Bill Rises Again

Retrieved on: 
Saturday, June 4, 2022
Centers for Disease Control and Prevention, Life, Death, Assembly, Safety, LGBTQ, ACTION, Animal, National Institute on Drug Abuse, Alcohol Justice, SB, Policy, City, CDC, Center, Public affairs, Senate, Violence, Restaurant, State, Public policy, LGB, Alcohol industry, SAN, Industry, STOP, Small business, Public health, ABC, National Institute, OTS, Housing, Binge drinking, DUI, Road traffic safety, Health insurance, Online gambling, Nightclub

SAN FRANCISCO, June 4, 2022 /PRNewswire/ -- Alcohol Justice is condemning State Senator Scott Wiener's 4th attempt since 2017 to extend alcohol hours of service in California. Wiener "gutted and amended" SB 930, a bill originally relating to housing which passed the Senate in May. Now it's a bill in the Assembly that would allow 7 cities in California to extend alcohol sales in bars and restaurants to 4 a.m. All of Wiener's previous attempts to extend alcohol sales have failed.

Key Points: 
  • Wiener "gutted and amended" SB 930 , a bill originally relating to housing which passed the Senate in May.
  • "This is his fourth attempt to disrupt the protections of a uniform closing time in California.
  • If passed it will allow a poorly conceived "pilot project" to turn much of the state's population into "Splash Zone" lab animals."
  • "The San Francisco State Senator continues to turn his back on common sense by authoring another dangerous 4 a.m. bill," said Michael Scippa, Public Affairs Director at Alcohol Justice.

Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity

Retrieved on: 
Tuesday, May 24, 2022
Joint, JBJS, Helmholtz Institute Ulm, Anatomy, Dipterocarpus conformis, Image, U.S. Securities and Exchange Commission, Arthralgia, Journal, Surgeon, TKA, RWTH Aachen University, Patient, NASDAQ, Knee, Health, Solution, Private Securities Litigation Reform Act, Comparison, Biomedical engineering, Cluster analysis, Trial of the century, Bone, Knee replacement, OTS, Research, Patent, Identity, Biomedicine, Technology, Growth, GLOBE, Security (finance), Risk, Medical device, Dentistry

The study, published in The Knee1, found that knee shape occurs independently from characteristics typically used to identify patients.

Key Points: 
  • The study, published in The Knee1, found that knee shape occurs independently from characteristics typically used to identify patients.
  • This recent clinical study further underscores the value of precisely matching a replacement joint with the specific anatomy of each patient.
  • The absence of predictable shapes or morphotypes makes it difficult to further reduce the bone to implant mismatch with off-the-shelf implants, note the authors.
  • This showed that there are no relevant identifiers, e.g., gender, body type, or ethnicity which influence the shape of the knee joint.

Kinspire Launches Innovative "Hybrid" Occupational Therapy Platform in Texas and Pennsylvania

Retrieved on: 
Tuesday, May 24, 2022
Student, Research, Family, Parent, OTS, Doctor of Health Science, Occupational therapy, Entrepreneurship, Post Secondary Transition for High School Students with Disabilities, CEO, Medicine, Tutoring

DENVER, May 24, 2022 /PRNewswire/ -- Kinspire, a teletherapy platform reinventing how children and families receive developmental support, announced today that its service has expanded to Texas and Pennsylvania.

Key Points: 
  • DENVER, May 24, 2022 /PRNewswire/ -- Kinspire, a teletherapy platform reinventing how children and families receive developmental support, announced today that its service has expanded to Texas and Pennsylvania.
  • Kinspire uses a "hybrid" approach of live pediatric occupational therapy (OT), asynchronous services provided by licensed therapists dedicated to each family, and on-demand content designed to increase parental involvement, comfort, and preparedness.
  • Traditional session-based occupational therapy limits a child's potential progression by restricting OT to only one modality of care scheduled sessions.
  • Founded by Rob Seigel, Lily Baiser, and Nate Ruiz, Kinspire is a pediatric occupational therapy platform with a "hybrid" approach of live sessions, asynchronous support, and on-demand content designed to best meet the needs of children and their families.

Education Resources, Inc. Releases New Online Course - "Baby Beats and Breaths: Therapeutic Interventions for the Premature Infant with Cardiopulmonary Compromise" with International Expert Holly Schifsky

Retrieved on: 
Tuesday, May 3, 2022
ERI, Open educational resources, Education, Patient, Person-centered therapy, Review, Therapy, CNT, PTS, OTS, OTR/L, Medicine

BOSTON, May 3, 2022 /PRNewswire/ -- Education Resources, Inc., a leading continuing education provider for physical therapists, occupational therapists, and speech-language pathologists, is pleased to announce the online launch of "Baby Beats and Breaths: Therapeutic Interventions for the Premature Infant with Cardiopulmonary Compromise", taught by internationally renowned instructor, Holly Schifsky, OTR/L, CNT, NTMTC, CBIS.

Key Points: 
  • Participants can register for "Baby Beats and Breaths: Therapeutic Interventions for the Premature Infant with Cardiopulmonary Compromise" on ERI's website and review ERI's complete list of online and live webinar offerings.
  • This online course was previously recorded from a live webinar in January 2022.
  • Participants can now access this exclusive online learning opportunity from the convenience or their home for $319/person.
  • The online format includes access to the entire course and all downloadable handout materials for one year, earning 15.5 contact hours (1.55 CEUs) upon completion.

Avid Delivers Tech Previews at NAB Show Promoting the Future of Remote Collaboration in Video Production

Retrieved on: 
Friday, April 22, 2022
Cloud, People, News, Microsoft, Microsoft Teams, Lists of composers, Technology, AVID, Secure Reliable Transport, NAB, Vongo (video on demand service), Life, Music, NAB Show, Organization, GLOBE, Apple TV, Television, Las Vegas Convention and Visitors Authority, Azure, Workforce, Social media, Media Composer, OTS, Nasdaq, Editorial, Solution, IP, Sport, Broadcaster, SRT, Video game, Video game console, Haivision

BURLINGTON, Mass., April 22, 2022 (GLOBE NEWSWIRE) -- Next week at the NAB Show in Las Vegas, Avid ( Nasdaq: AVID ), in collaboration with Microsoft and Haivision, will unveil technology previews of solutions that create more powerful remote collaboration.

Key Points: 
  • BURLINGTON, Mass., April 22, 2022 (GLOBE NEWSWIRE) -- Next week at the NAB Show in Las Vegas, Avid ( Nasdaq: AVID ), in collaboration with Microsoft and Haivision, will unveil technology previews of solutions that create more powerful remote collaboration.
  • The most recent release of Media Composer video editing software delivers native over-the-shoulder (OTS) remote collaboration.
  • Avids offerings for remote collaboration and media production in the cloud benefit from its longstanding Strategic Cloud Alliance with Microsoft and integration with the Azure cloud platform.
  • Augmenting the service in a technology preview at NAB Show, Avid will feature MediaCentral | Stream demonstrating IP contribution into and out of Avid | Edit On Demand.

AIC And GRAID Technology Announce Customer Engagement Partnership Targeted at Key System Integrators

Retrieved on: 
Thursday, April 21, 2022
CEO, Technology, Solid-state drive, Twitter, NVM Express, RAID, CRN, CA, GLOBE, LinkedIn, OTS, COTS, NAB Show, IOPS, SSD, Silicon, Industry, Partnership, AIC, Online gambling, Online shopping

"There is a tremendous amount of upside for both companies in this new relationship," said Leander Yu, CEO and President of GRAID Technology.

Key Points: 
  • "There is a tremendous amount of upside for both companies in this new relationship," said Leander Yu, CEO and President of GRAID Technology.
  • "After extensive testing on AIC platforms, it's clear the partnership between GRAID and AIC will help our customers drive a competitive advantage in the market," said Hank Lu, Executive Vice President at AIC.
  • As a formal kickoff to the partnership, GRAID Technology will exhibit in AIC's booth at the upcoming NAB Show in Las Vegas from April 23-27, 2022.
  • AIC leads the industry with over 25 years of experience in mechanical, electronic, system-level engineering as well as a dedication to innovation and customer satisfaction.

OTS and Caltrans Launch New ‘Get Off Your Apps’ Education Campaign and Video Contest to Encourage Drivers to Put the Phone Away

Retrieved on: 
Friday, April 15, 2022
Teens, Construction & Property, Automotive, General Automotive, Public Policy, Government, Other Automotive, State, Local, Consumer, Other Construction & Property, Travel, Awareness, California Department, PSA, Road traffic safety, CHP, Compliance, California Office of Environmental Health Hazard Assessment, OTS, Social media, Distracted driving, California Highway Patrol, Solution, Safety, Radio, PSAS, Attention, View, IHeartMedia, Mobile phone, California Department of Transportation

The California Office of Traffic Safety (OTS) and California Department of Transportation (Caltrans) announced today a new statewide education campaign and video contest that encourages drivers to Get Off Your Apps and put the phone away.

Key Points: 
  • The California Office of Traffic Safety (OTS) and California Department of Transportation (Caltrans) announced today a new statewide education campaign and video contest that encourages drivers to Get Off Your Apps and put the phone away.
  • The phone is not your friend when youre driving, OTS Director Barbara Rooney said.
  • Put the phone away and put all your attention on the task of driving.
  • On April 20, CHP officers will participate in a statewide enforcement campaign specifically focused on citing drivers caught violating the hands-free cell phone law.

BriaCell Presents Development Details of Bria-OTS™ Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022

Retrieved on: 
Tuesday, April 12, 2022
Patient, Veni, vidi, vici, Allele, News, Cancer, Breast cancer, EDGAR, Genetic engineering, Poster, Biotechnology, Clinical trial, U.S. Securities and Exchange Commission, Woman, LLC, Association, Population, Immunotherapy, Center, R, Toronto Stock Exchange, Compliance, Forward-looking statement, GLOBE, OTS, Nasdaq, Company, Center for Biologics Evaluation and Research, CGMP, American Association for Cancer Research, Gene, TSX, Safety, Immortalised cell line, HLA, American Association, SEDAR, AACR, Therapy, Survival, BCT, Medical imaging, Pharmaceutical industry, Medical device, Vaccine, Research

Bria-OTS will be used to treat patients with advanced breast cancer, providing patients with readily available personalized treatment.

Key Points: 
  • Bria-OTS will be used to treat patients with advanced breast cancer, providing patients with readily available personalized treatment.
  • We intend to treat each patient with a personalized formulation, based on a simple saliva test that determines each patient's HLA types.
  • Poster presentation details are summarized below:
    BriaCells lead candidate, the Bria-IMT regimen, has produced a safe and effective immune response and disease control in heavily pre-treated advanced breast cancer patients.
  • Patients that match the Bria-IMT immunotherapy treatment at least at 1 HLA type were more likely to experience clinical benefit.

BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial

Retrieved on: 
Thursday, April 7, 2022
Epacadostat, Therapy, CGMP, National, Population, Date, Bria, Veni, vidi, vici, National Cancer Institute, Immunotherapy, Center for Biologics Evaluation and Research, Clinical trial, Compliance, Survival, AACR, Ernest, Molecular biology, Woman, American Association, Cancer, BCT, TSX, LLC, Cooperative research and development agreement, Center, Association, American Association for Cancer Research, Safety, Breast cancer, Nasdaq, GLOBE, Immortalised cell line, Time, HLA, Development, NCI, OTS, Patient, Phase, Pharmaceutical industry, Medical imaging, Research

BriaCell and National Cancer Institute collaborating on Bria-OTS, BriaCells off-the-shelf personalized immunotherapy, as a treatment for cancer.

Key Points: 
  • BriaCell and National Cancer Institute collaborating on Bria-OTS, BriaCells off-the-shelf personalized immunotherapy, as a treatment for cancer.
  • BriaCell expects Bria-OTS to enter an open-label Phase I/IIa clinical trial designed to evaluate its safety and efficacy in patients with advanced breast cancer.
  • The goal is to develop novel therapeutics for future clinical collaborations, allowing cancer patients to potentially benefit from potent and personalized cancer immunotherapy in the future.
  • BriaCell has two advanced breast cancer immunotherapy programs in different stages of clinical development:
    Bria-IMT: BriaCell is actively enrolling and dosing advanced breast cancer patients in the Phase I/IIa combination study with Incytes checkpoint inhibitor, retifanlimab, and its immunomodulator, epacadostat.